Education
About Us
Working with TipRanks
Follow Us
Vaxcyte, Inc. (PCVX)
:PCVX
PCVX Analyst Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PCVX Stock 12 Month Forecast
Average Price Target
$147.17
▲(97.12% Upside)
| Highest Price Target$160.00 | Average Price Target$147.17 | Lowest Price Target$135.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
Reiterated
03/07/25
Mizuho Securities
Reiterated
03/06/25
Leerink Partners
Reiterated
02/26/25
Goldman Sachs
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/26/25
Needham
Reiterated
02/26/25
BTIG
Reiterated
02/25/25
Jefferies
$129→$146
Buy
95.55%
Upside
Reiterated
11/06/24
Vaxcyte (PCVX) PT Raised to $146 at JefferiesJefferies analyst Roger Song raised the price target on Vaxcyte (NASDAQ: PCVX) to $146.00 (from $129.00) while maintaining a Buy rating.
Guggenheim
$101→$130
Buy
74.12%
Upside
Reiterated
09/04/24
Vaxcyte price target raised to $130 from $101 at GuggenheimVaxcyte price target raised to $130 from $101 at Guggenheim
Citi
$102→$101
Buy
35.28%
Upside
Reiterated
05/10/24
Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
03/07/25
Mizuho Securities
Reiterated
03/06/25
Leerink Partners
Reiterated
02/26/25
Goldman Sachs
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/26/25
Needham
Reiterated
02/26/25
BTIG
Reiterated
02/25/25
Jefferies
$129→$146
Buy
95.55%
Upside
Reiterated
11/06/24
Vaxcyte (PCVX) PT Raised to $146 at JefferiesJefferies analyst Roger Song raised the price target on Vaxcyte (NASDAQ: PCVX) to $146.00 (from $129.00) while maintaining a Buy rating.
Guggenheim
$101→$130
Buy
74.12%
Upside
Reiterated
09/04/24
Vaxcyte price target raised to $130 from $101 at GuggenheimVaxcyte price target raised to $130 from $101 at Guggenheim
Citi
$102→$101
Buy
35.28%
Upside
Reiterated
05/10/24
Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)
Best Analysts Covering Vaxcyte
Which Analyst Should I Follow If I Want to Buy PCVX and Sell After:
1 Month
xxx
Success Rate
10/14 ratings generated profit
Average Return
+6.23%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +6.23% per trade.
3 Months
xxx
Success Rate
13/20 ratings generated profit
Average Return
+17.70%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +17.70% per trade.
1 Year
Success Rate
18/24 ratings generated profit
Average Return
+39.90%
reiterated a buy rating 26 days ago
Copying Joseph Stringer's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +39.90% per trade.
2 Years
xxx
Success Rate
19/24 ratings generated profit
Average Return
+111.02%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 79.17% of your transactions generating a profit, with an average return of +111.02% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PCVX Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
1
3
4
12
12
Buy
18
9
6
4
5
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
12
11
17
18
Each month's total comprises the sum of three months' worth of ratings.
PCVX Financial Forecast
PCVX Stock Forecast FAQ
What is PCVX’s average 12-month price target, according to analysts?
Based on analyst ratings, Vaxcyte, Inc.’s 12-month average price target is $147.17.
What is PCVX’s upside potential, based on the analysts’ average price target?
Vaxcyte, Inc. has 97.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PCVX a Buy, Sell or Hold?
Vaxcyte, Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
What is Vaxcyte, Inc.’s price target?
The average price target for Vaxcyte, Inc. is $147.17. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $160.00 ,the lowest forecast is $135.00. The average price target represents 97.12% Increase from the current price of $74.66.
The highest analyst price target is $160.00 ,the lowest forecast is $135.00. The average price target represents 97.12% Increase from the current price of $74.66.
What do analysts say about Vaxcyte, Inc.?
Vaxcyte, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of PCVX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.